SITC connectED Patient Portal


Browse online courses and resources for patients by cancer type, general immunotherapy courses, or click All Patient Courses to view all available courses. Click the Additional Patient Resources button to explore more SITC resources for patients.


Collapse 2019 Patient Course: Understanding Cancer Immunotherapy - Fifth Edition

Course Description

This easy-to-use, interactive course provides patients and caregivers with many resources and basic education on cancer and immunotherapy. The course is designed to be self-directed and is based on the Understanding Cancer Immunotherapy - 5th Edition Patient Resource Guide. There are five modules offered, and learners can access one or all of the modules, depending upon their interest level for each topic: 

 

first_screen_2.png

 

 

 

 

 

 

 

 

 

 

 

 

Module Content

Your Treatment and Providers - This module talks about how cancer treatment may proceed, including what tests a patient may undergo,what doctors may look for to determine the best treatment options, and healthcare providers that are involved in cancer care. It also provides links to SITC resources by type of cancer.

Cancer and The Immune System - This module provides education on what cancer is, why it forms, how it relates to the immune system as well as how it can evade the immune system.  This is a helpful precursor to the Types of Immunotherapy module which explains how different immunotherapies work.

Types of Immunotherapies - This module has interactive animations that help describe how different types of cancer immunotherapy work to treat cancer. In addition, there is an infographic of the FDA-approved cancer immunotherapies by disease.

The Importance of Reporting Side Effects - This module discusses possible side effects of cancer immunotherapy and stresses why it is important to report side effects to care providers. It also provides links to more resources on this topic.

Empower Yourself With Patient Resources - This module has many links to a wide variety of resources, including financial assistance resources, clinical trial search engines, patient/caregiver support groups and more information and courses by disease type.

 

 

Target Audience

This activity is intended for cancer patients and their caregivers.

 

Educational Objectives

After completing this activity, the participant should:

  • Have an improved understanding of cancer immunotherapy.
  • Be able to find and access support and resources relevant to their cancer and/or situation. 

 

Available Beginning:  5/30/19

Approximate time to complete: 30 minutes

 

This online patient education activity was produced with the generous support of the following companies.

 


SITC Online Education Disclaimer

A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.




 

Original Course Date: May 30, 2019
MORE INFOMORE INFO 2019 Patient Course: Understanding Cancer Immunotherapy - Fifth Edition
Collapse Adjuvant Therapy in Melanoma: What Is It and Is It Right For Me?

Access Course

This article is for people who want to understand how biomarkers may affect their cancer treatment choices. It's also for their care partners, and others who want to learn more about the topic. The goal is to help you know what to discuss with your healthcare team about testing for biomarkers and what the results mean for your treatment.

 

 

 

 

 

 

 

You'll explore:

  • What adjuvant therapy in melanoma is
  • Who adjuvant therapy is recommended for
  • The potential benefits of adjuvant therapy
  • About side effects of adjuvant therapy
  • Questions to ask your provider about adjuvant therapy

 

Available beginning: Dec. 18, 2018

 

Approximate Time to Complete: 30 minutes

 

 

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: December 18, 2018
MORE INFOMORE INFO Adjuvant Therapy in Melanoma: What Is It and Is It Right For Me?
Collapse Beyond Chemotherapy for Treatment of Head and Neck Cancer

Access Course

 

886788-img1.jpgThis article is for people who have head and neck cancer, their care partners, and others who want to learn more about treatment. The goal is to learn about your treatment options after chemotherapy.

 

You will learn about:

- Treatments for people newly diagnosed with head and neck cancer

- Treatments for head and neck cancer that has spread to other parts of the body (metastasized) or came back after chemotherapy

- Immunotherapy for head and neck cancer

- Questions to ask your healthcare team

 

 

Approximate Time to Complete: 20 minutes

 

Course Available Beginning: Nov. 27, 2017

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: November 27, 2017
MORE INFOMORE INFO Beyond Chemotherapy for Treatment of Head and Neck Cancer
Collapse Biomarkers and Cancer: Do They Matter for Me?

Access Course

This article is for people who want to understand how biomarkers may affect their cancer treatment choices. It's also for their care partners, and others who want to learn more about the topic. The goal is to help you know what to discuss with your healthcare team about testing for biomarkers and what the results mean for your treatment.

 

 

 

 

 

 

 

 

You'll explore:

  • What biomarkers are and how they show changes in your cancer cells
  • Which tests your provider may order to find certain biomarkers
  • How immunotherapy offers another treatment option for certain cancers with specific biomarkers
  • What questions to ask your healthcare provider about biomarker testing and what the results may mean for you

 

Available beginning: Nov. 28, 2018

 

Approximate Time to Complete: 30 minutes

 

 

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: November 28, 2018
MORE INFOMORE INFO Biomarkers and Cancer: Do They Matter for Me?
Collapse Cancer Immunotherapy: Alerting Your Team to Side Effects

Access Course

This article is for people who are taking an immunotherapy medicine for cancer or their caregivers who want to learn more about cancer immunotherapy. The goal is to help you know when and how to take action if you have side effects of your immunotherapy medicines.

 

 

 

 

 

 

You will learn about:

 

  • Immunotherapy medicines used to treat cancer
  • Common and serious side effects of cancer immunotherapy
  • What to do if you have side effects of your immunotherapy
  • How to be prepared and what to tell your providers if you have side effects
  • How side effects are treated
  • Questions to ask your cancer provider about immunotherapy

 

Available beginning: January 29th, 2019

 

Approximate Time to Complete: 30 minutes

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: January 29, 2019
MORE INFOMORE INFO Cancer Immunotherapy: Alerting Your Team to Side Effects
Collapse Immunotherapy Side Effects: Talking with Your Melanoma Care Team

Access Course

 

patient_medscape-melanoma_side_effects.jpgThis article is for people who are taking checkpoint inhibitor medicines for metastatic melanoma, their care partners, and others who want to learn about treatment side effects.

 

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Nov. 8, 2016

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: November 08, 2016
MORE INFOMORE INFO Immunotherapy Side Effects: Talking with Your Melanoma Care Team
Collapse Introduction to Cancer Immunotherapy and the Immune System

Access the updated patient course, 2019 Patient Course: Understanding Cancer Immunotherapy – Fifth Edition

 

This activity is based on the Patient Resource Guide, Understanding Cancer Immunotherapy 4th Edition (published in December 2017), designed for newly diagnosed and restaged cancer patients and their caregivers. This interactive activity takes a closer look at how the immune system works to fight against cancer, cancer immunotherapy treatment types and clinical trials.

d615c873-290c-4553-bd5d-bcb549ff6cb7.jpg

 

SITC Online Education Disclaimer

A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 

Available beginning: May 22, 2018

 

Approximate Time to Complete: 30 minutes

 

 

 

This online patient education activity was produced with generous support from:

35d50fdb-789b-42f6-8759-5ae752b880bc.jpg  
                  
                   

 

 

 

 

Original Course Date: May 22, 2018
MORE INFOMORE INFO Introduction to Cancer Immunotherapy and the Immune System
Collapse Is Immunotherapy for Lung Cancer the Same Thing as Chemotherapy?

Access Course

 

patient_medscape-_immunotherapy_the_same_as_chemo.jpgThis activity is for people with non-small cell lung cancer (NSCLC) who want to learn more about how immunotherapy differs from chemotherapy.

 

 

 

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Oct. 20, 2016

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: October 20, 2016
MORE INFOMORE INFO Is Immunotherapy for Lung Cancer the Same Thing as Chemotherapy?
Collapse Is Immunotherapy Right for My Lung Cancer?

Access Course

 

medscape-_LungPatient2.jpgThis activity is for people with non-small cell lung cancer who want to learn more about why, how, and when their care team may consider using immunotherapy as part of their treatment.

 

 

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Nov. 8, 2016

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: November 08, 2016
MORE INFOMORE INFO Is Immunotherapy Right for My Lung Cancer?
Collapse Kidney Cancer Treatments: Is One Option Better Than Another for Me?

Access Course

 

888494-fig1.pngThis article is for people who’ve had treatment for kidney cancer that has now spread, called metastatic renal cell carcinoma (mRCC). It’s also for their care partners and others who want to learn more about the next treatment choices. The goal is to learn about all your treatment options so you can better decide with your care team what’s right for you.

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Dec. 16, 2016

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: December 16, 2016
MORE INFOMORE INFO Kidney Cancer Treatments: Is One Option Better Than Another for Me?
Collapse Lung Cancer Treatment: Talking to All Your Healthcare Providers

Access Course

 

883529-fig1.jpgThis article is for people with advanced lung cancer, care partners, and others who want to learn about talking to their healthcare providers about lung cancer treatment with immunotherapy.

 

You will learn:

- Why and how talking with all of your healthcare providers helps

- Your role in helping your cancer care providers and others to work as a team

- What medical information to share and how to keep it in order

- Questions to ask your healthcare providers

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Dec. 7, 2017

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: December 07, 2017
MORE INFOMORE INFO Lung Cancer Treatment: Talking to All Your Healthcare Providers
Collapse Management of Advanced Bladder Cancer: What You Should Know

Access Course

 

This article is for people who have advanced bladder cancer or anyone who wants to learn more about advanced bladder cancer. The goal of this patient education activity is to make patients more aware of available treatment options for advanced bladder cancer.

 

 

 

 

 

You will learn about:

 

  • What chemotherapy is and how it is used to treat advanced bladder cancer
  • What checkpoint inhibitors are and how they are used to treat advanced bladder cancer
  • The potential side effects of chemotherapy and checkpoint inhibitors
  • Why the side effects from chemotherapy and checkpoint inhibitors are different
  • Questions to ask your doctor

 

Available beginning: April 26, 2019

 

Approximate Time to Complete: 30 minutes

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: April 26, 2019
MORE INFOMORE INFO Management of Advanced Bladder Cancer: What You Should Know
Collapse The Global Promise of Cancer Immunotherapy

The Global Promise of Cancer Immunotherapy Recorded Webinar provides education for patients, caregivers, and patient advocates on how the immune system can be harnessed to fight cancer. The Jan. 30, 2018 webinar, provided by the Society for Immunotherapy of Cancer (SITC), was provided in collaboration with the European Cancer Patient Coalition (ECPC).

 

Presenters of the webinar were Howard L. Kaufman, MD, FACS, an expert in the cancer immunotherapy field and past SITC president, and Jacqueline Smith, MS, MA, a cancer survivors who has been successfully treated with cancer immunotherapy.

 

The recorded webinar includes a question and answer session in which webinar attendees asked questions and received guidance and feedback from the webinar presenters. The question and answer session includes discussion on clinical trials, side effects, and insurance coverage.

 

Webinar Faculty

Howard L. Kaufman MD, FACS

Jacqueline Smith MS, MA

 

Webinar Date

January 30, 2018

 

View Recorded Webinar

 

 Click here to access the recorded webinar.

 

Global_Promise_Webinar_Social_Media.jpg

The Society for Immunotherapy of Cancer is pleased to offer the recorded webinar with subtitles in Spanish, Portuguese, simplified Chinese, and Hindi along with translated versions of the accompanying slides. Please click on one of the links below to view translated webinar recording and translated slide deck. 

Promesa Global de la Inmunoterapia Contra el Cáncer - Spanish 

A Promessa Global da Imunoterapia para o tratamento do Câncer – Portuguese 


Simplified Chinese

Hindi
 

 

This webinar was produced with generous support from EMD Serono. EMD Serono, is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada.

Original Course Date: January 30, 2018
MORE INFOMORE INFO The Global Promise of Cancer Immunotherapy
Collapse Treating Your Head and Neck Cancer: You

Access Course

 

889824-img1.pngThis article is for people who have advanced head and neck cancer and want to learn about working with their care team to share information about treatment and side effects and get support.

 

 

 

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Feb. 8, 2018

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: February 08, 2018
MORE INFOMORE INFO Treating Your Head and Neck Cancer: You
Collapse Understanding Cancer Immunotherapy

Access the updated patient course, 2019 Patient Course: Understanding Cancer Immunotherapy – Fifth Edition

 

Designed for patients and caregivers, this interactive activity takes a closer look at the potential side effects of cancer immunotherapy. Based on the Patient Resource Guide, Understanding Cancer Immunotherapy 3rd Edition, this activity provides information about side effects that patients may experience while receiving cancer immunotherapy treatment and how to manage these side effects.

d615c873-290c-4553-bd5d-bcb549ff6cb7.jpg

 

SITC Online Education Disclaimer

A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 

Available beginning: December 22, 2017

 

Approximate Time to Complete: 30 minutes

 

 

This online patient education activity was produced with generous support from

35d50fdb-789b-42f6-8759-5ae752b880bc.jpg cc9788f6-5b63-4af3-ab4d-61d7a1b1e684.jpg

 

Original Course Date: December 22, 2017
MORE INFOMORE INFO Understanding Cancer Immunotherapy
Collapse What Treatment is Right for My Metatastic Melanoma

Access Course

 

patient_medscape-_melanoma.jpg

 

This article is for people who have metastatic melanoma, their care partners, and others who want to learn about immunotherapy. This activity is intended for oncologists, dermatologists, pathologists, and healthcare practitioners who care for patients with metastatic melanoma. The goal of this activity is to educate clinicians in the practical application of recently approved systemic.

 

Upon completion of this activity, participants will be able to:

Select opitmal therapy for patients with metastatic melanoma that harbors v600 BRAF mutations and for patients with wild-type BRAF. Explain the role of immunotherapy in patients with V600 BRAF mutation-positive metastatic melanoma. Outline a sequential treatment strategy for patients with V600 BRAF mutation-positive metastatic melanoma. Describe how to manage side effects and assess response to immunotherapy and targeted therapy in patients being treated for metastatic melanoma. 

 

 

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Oct. 19, 2016

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: October 19, 2016
MORE INFOMORE INFO What Treatment is Right for My Metatastic Melanoma
Collapse When Is Immunotherapy Right for My Lung Cancer?

Access Course

 

885207-fig1.pngThis article is for people with non-small cell lung cancer (NSCLC), their care partners, and others who want to learn about immunotherapy for the condition. The goal is to understand why and when immunotherapy might be right for you.

 

 

 

 

 

 

Approximate Time to Complete: 15 minutes

 

Course Available Beginning: Oct. 23, 2017

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Original Course Date: October 23, 2017
MORE INFOMORE INFO When Is Immunotherapy Right for My Lung Cancer?


Patient Courses by Cancer Type